ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value (IKT)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value
Symbol: IKT
Shares outstanding: 70,721,563 shares
Disclosed Ownership: 3,529,006 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:35:58 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	3,529,006	0	3,529,006	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	3,529,006	0	3,529,006	/s/ Steven Boyd	Steven Boyd